title: The authors reply.
authors.affiliation: Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, Tokyo, Japan Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, Tokyo, Japan Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, Tokyo, Japan.
authors.forename: Masao
authors.initials: M
authors.lastname: Iwagami
authors.forename: Hideo
authors.initials: H
authors.lastname: Yasunaga
authors.forename: Kent
authors.initials: K
authors.lastname: Doi
authors.forename: Eisei
authors.initials: E
authors.lastname: Noiri
mesh_terms: D000005:Abdomen / Q000503:physiopathology*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D005260:Female; D006464:Hemoperfusion / Q000401:mortality*; D006801:Humans; D007416:Intestinal Perforation / Q000150:complications*; D008297:Male; D011112:Polymyxin B / Q000008:administration & dosage*; D011183:Postoperative Complications / Q000401:mortality*; D012772:Shock, Septic / Q000401:mortality*
chemical_list: D000900:Anti-Bacterial Agents; D011112:Polymyxin B